Dynamic International Prognostic Scoring System for Myelofibrosis

Loading...

References

  1. A. Tefferi. Risk models in myelofibrosis—the past, present, and future. American Journal of Hematology, 2024
  2. N M Kröger. Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.. Leukemia, 2015
  3. N. Kröger. Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis.. Blood, 2015
  4. Bart L. Scott. The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.. Blood, 2012
  5. M. Ditschkowski. Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis. Haematologica, 2012
  6. N. Gangat. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011
  7. Tiziano Barbui. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011
  8. C. Elena. Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS. Haematologica, 2011
  9. F. Passamonti. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).. Blood, 2010